Europe — Sales to customers (Note 9)
Geographic · Sales to customers (Note 9)Johnson & Johnson Europe — Sales to customers (Note 9) increased by 1.0% to $5.44B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $4.91B to $5.44B. Over 2 years (FY 2021 to FY 2024), Europe — Sales to customers (Note 9) shows relatively stable performance with a 3.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or demand in Europe, while a decrease suggests regional economic headwinds or competitive pressure.
Detailed definition
Represents the total revenue generated from external customers located within the European geographic region. This metri...
Peer comparison
Comparable to regional revenue disclosures provided by other multinational corporations in the pharmaceutical and medical device sectors.
jnj_segment_europe_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.41B | $5.67B | $5.59B | $5.96B | $6.02B | $6.09B | $5.52B | $6.33B | $4.73B | $5.16B | $5.21B | $4.91B | $4.92B | $5.11B | $5.39B | $5.44B |
| QoQ Change | — | +4.7% | -1.4% | +6.7% | +1.1% | +1.0% | -9.2% | +14.6% | -25.3% | +9.2% | +1.0% | -5.8% | +0.1% | +3.8% | +5.4% | +1.0% |
| YoY Change | — | — | — | — | +11.3% | +7.4% | -1.1% | +5.1% | -22.3% | — | -17.7% | +4.0% | — | -1.0% | +3.3% | +10.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's europe — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported europe — sales to customers (note 9) of $5.44B in Q3 2025.
- How has Johnson & Johnson's europe — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's europe — sales to customers (note 9) increased by 10.7% year-over-year, from $4.91B to $5.44B.
- What is the long-term trend for Johnson & Johnson's europe — sales to customers (note 9)?
- Over 2 years (2021 to 2024), Johnson & Johnson's europe — sales to customers (note 9) has grown at a 3.2% compound annual growth rate (CAGR), from $18.98B to $20.21B.
- What does europe — sales to customers (note 9) mean?
- Total revenue earned from customers located in Europe.